A	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
tachycardia	tachycardia	O	DISEASE	OTHERS	I
related	related	O	O	O	O
to	to	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
pretreatment	pretreatment	O	O	O	O
.	.	O	O	O	O

Suboptimal	suboptimal	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
duration	duration	O	O	O	O
is	is	O	O	O	O
commonly	commonly	O	O	O	O
encountered	encountered	O	O	O	O
in	in	O	O	O	O
electroconvulsive	electroconvulsive	O	O	O	O
therapy	therapy	O	O	O	O
practice	practice	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
in	in	O	O	O	O
older	older	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
higher	higher	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
thresholds	thresholds	O	O	O	O
.	.	O	O	O	O

Intravenous	intravenous	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
commonly	commonly	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
improve	improve	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
duration	duration	O	O	O	O
and	and	O	O	O	O
quality	quality	O	O	O	O
in	in	O	O	O	O
such	such	O	O	O	O
patients	patients	O	O	O	O
and	and	O	O	O	O
is	is	O	O	O	O
generally	generally	O	O	O	O
well	well	O	O	O	O
tolerated	tolerated	O	O	O	O
aside	aside	O	O	O	O
from	from	O	O	O	O
occasional	occasional	O	O	O	O
reports	reports	O	O	O	O
of	of	O	O	O	O
relatively	relatively	O	O	O	O
benign	benign	O	O	O	O
ventricular	ventricular	O	O	OTHERS	I
ectopy	ectopy	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
no	no	O	O	O	O
previous	previous	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
or	or	O	O	O	O
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
who	who	O	O	O	O
developed	developed	O	O	O	O
sustained	sustained	O	O	O	O
bigeminy	bigeminy	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
brief	brief	O	O	O	O
runs	runs	O	O	O	O
of	of	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
tachycardia	tachycardia	O	DISEASE	OTHERS	I
after	after	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
intravenous	intravenous	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
generally	generally	O	O	O	O
well	well	O	O	O	O
tolerated	tolerated	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
clinician	clinician	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
potential	potential	O	O	O	O
for	for	O	O	O	O
unpredictable	unpredictable	O	O	O	O
and	and	O	O	O	O
serious	serious	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
.	.	O	O	O	O

